ABH secretor status, as judged by the Lewis phenotypes, in Norwegian survivors from meningococcal disease.
Survivors from meningococcal disease (serogroups B and C) and a control series (blood donors) were examined for their ability to secrete ABH blood group substance. The examination was done indirectly by determining their Lewis phenotypes. There was no significant difference in the secretor status between the two groups.
Kornstad
L
L
National Institute of Public Health, Oslo, Norway.
Heistøo
A L
AL
Michaelsen
T E
TE
Bjune
G
G
D000017:ABO Blood-Group System / Q000097:blood; D000293:Adolescent; D000328:Adult; D001782:Blood Donors; D004198:Disease Susceptibility; D005647:Fucosyltransferases / Q000235:genetics; D006801:Humans; D007983:Lewis Blood Group Antigens / Q000097:blood*; D008589:Meningococcal Infections / Q000097:blood* / Q000503:physiopathology; D009345:Neisseria meningitidis / Q000145:classification; D009664:Norway; D010641:Phenotype; D012016:Reference Values; D012703:Serotyping; D000097631:Galactoside 2-alpha-L-fucosyltransferase
D000017:ABO Blood-Group System; D005647:Fucosyltransferases; D007983:Lewis Blood Group Antigens; D000097631:Galactoside 2-alpha-L-fucosyltransferase